SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen South African Variant with B.1.351 RBD Mutations (100 μg)


100 μg

100 μl buffer solution with 0.001% LMNG provided separately FREE OF CHARGE

All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. Spike protein of the mutant strain B.1.351, also commonly known as the “South Africa Variant”. It is a full-length protein, which is active in its native trimeric form, that is stabilized in LMNG detergent.

SARS-COV-2 Spike Antigen Variants Factsheet

SARS-CoV-2 Spike Antigen Variants MSDS

SA Variant w. B.1.351 RBD Mutations_Datasheet


Product Name: SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen (South African Variant)
WHO Label: Beta
UniProt Number: P0DTC2
SARS-CoV-2 Protein: South African Mutation B.1.351
Host: HEK293
Mutations that differ from SPIKE Protein: del 144, K417N, E484K, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H
Further Modifications: Furin cleavage site “RRAR” mutated to “GSAG”; K986P V987P
Buffer Composition: 20 mM Hepes pH 7.5; 150 mM NaCl, 0.001% LMNG
Molecular Weight: 142 kDa